between january and december 1985 , 17 children with advanced neuroblastoma who were greater than 1 year old ( 16 stage iv , one stage iii ) were administered cisplatin ( cpdd , 200 mg/m2 ) and etoposide ( vp-16 , 500 mg/m2 ) as a pilot study of toxicity and response rates for the european neuroblastoma study group ( ensg ) .
C0008838
cisplatin
C0027819
neuroblastoma